Navinci is pleased to highlight the publication of a new study in Nature Communications reporting findings from the ASTEROID Phase 1 clinical trial.
Naveni® technology has been referenced in a publication describing novel insights into the process of lysosomal degradation of mitochondria.
New publication out! Wåhlén et al. have just published the article: Differential impact of lipid raft depletion on platelet-derived growth factor (PDGF)-induced ERK1/2 MAP-kinase, SRC and AKT signaling – ScienceDirect In the study, they analyzed the co-localization of PDGFR-β and GRB2, PI3K or clathrin, using our Naveni Proximity Ligation Technology. Citation: “For this purpose, NaveniFlex…